ConductScience.org, home

Trial · NCT02009878

Results by group63

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Maximal Increase From Baseline in Serum Sodium Concentration Following Tolvaptan Administration.Tolvaptan 3.75 mg3.6Standard Deviation 3.3mmol/L
Maximal Increase From Baseline in Serum Sodium Concentration Following Tolvaptan Administration.Tolvaptan 7.5 mg5.3Standard Deviation 2.5mmol/L
Maximal Increase From Baseline in Serum Sodium Concentration Following Tolvaptan Administration.Tolvaptan 15 mg7.9Standard Deviation 5.3mmol/L
Cmax (Maximum (Peak) Plasma Concentration) for Tolvaptan in Plasma.Tolvaptan 3.75 mg37.7Standard Deviation 12.6ng/mL
Cmax (Maximum (Peak) Plasma Concentration) for Tolvaptan in Plasma.Tolvaptan 7.5 mg107Standard Deviation 48.9ng/mL
Cmax (Maximum (Peak) Plasma Concentration) for Tolvaptan in Plasma.Tolvaptan 15 mg157Standard Deviation 68.1ng/mL
Tmax (Time to Maximum (Peak) Plasma Concentration) for Tolvaptan in PlasmaTolvaptan 3.75 mg1.50Full Range 0.95 to 4.00hours
Tmax (Time to Maximum (Peak) Plasma Concentration) for Tolvaptan in PlasmaTolvaptan 7.5 mg2.00Full Range 1.00 to 4.00hours
Tmax (Time to Maximum (Peak) Plasma Concentration) for Tolvaptan in PlasmaTolvaptan 15 mg2.00Full Range 0.97 to 3.00hours
AUC Infinity (Area Under the Concentration-time Curve From Time Zero to Infinity) for Tolvaptan in PlasmaTolvaptan 3.75 mg244Standard Deviation 90.7ng·h/mL
AUC Infinity (Area Under the Concentration-time Curve From Time Zero to Infinity) for Tolvaptan in PlasmaTolvaptan 7.5 mg655Standard Deviation 373ng·h/mL
AUC Infinity (Area Under the Concentration-time Curve From Time Zero to Infinity) for Tolvaptan in PlasmaTolvaptan 15 mg1000Standard Deviation 361ng·h/mL
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 3.75 mg(Day 0) 12 hour (N= 10, 9, 9)-2.5Standard Deviation 1.3mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 7.5 mg(Day 0) 12 hour (N= 10, 9, 9)-2.3Standard Deviation 3.0mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 15 mg(Day 0) 12 hour (N= 10, 9, 9)-2.6Standard Deviation 2.2mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 3.75 mg(Day 1) 2 hour (N= 10, 10, 8)-2.0Standard Deviation 4.4mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 7.5 mg(Day 1) 2 hour (N= 10, 10, 8)2.4Standard Deviation 1.3mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 15 mg(Day 1) 2 hour (N= 10, 10, 8)1.7Standard Deviation 1.8mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 3.75 mg(Day 1) 4 hour (N= 10, 10, 8)-1.7Standard Deviation 4.7mmol/L
Change From Baseline in Serum Sodium ConcentrationsTolvaptan 7.5 mg(Day 1) 4 hour (N= 10, 10, 8)3.5Standard Deviation 3.0mmol/L

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02009878/results